Showing results (11-20 of 161) with videos related to
Sort By:
Pageof 17
Biomedicines|March 25, 2022
Definition of Castrate Resistant Prostate Cancer: New InsightsJuan Morote, Adriana Aguilar, Jacques Planas, et al.Case Reports in Oncological Medicine|November 3, 2012
Bladder cancer in an inguinoscrotal vesical herniaLucas Regis, Fernando Lozano, Jacques Planas, et al.Archivos Espanoles De Urologia|June 11, 2014
[Optimization of follow up in prostate cancer active surveillance]Ana Celma Domènech, Jacques Planas Morin, Juan Morote RoblesArchivos Espanoles De Urologia|April 3, 2014
Comparison of the initial robot-assisted radical prostatectomy results with laparoscopic radical prostatectomyFernando Agreda, Carles Raventos, Jacques Planas, et al.Cancers|July 14, 2023
A Systematic Review of the Current Status of Magnetic Resonance-Ultrasound Images Fusion Software Platforms for Transperineal Prostate BiopsiesNahuel Paesano, Violeta Catalá, Larisa Tcholakian, et al.Clinical Genitourinary Cancer|January 9, 2020
Assessing the Clinical Benefit of UBC Rapid in the Surveillance and Initial Diagnosis of Bladder CancerFernando Agreda Castañeda, Carles Xavier Raventós Busquets, Juan Morote RoblesUrologia Internationalis|May 18, 2005
Gastric cancer in augmentation gastrocystoplastySalvador Esquena Fernández, José María Abascal, Edmundo Tremps, et al.Environmental and Molecular Mutagenesis|October 5, 2018
Micronuclei frequency in urothelial cells of bladder cancer patients, as a biomarker of prognosisFelicidad Espinoza, Lluis Cecchini, Juan Morote, et al.International Journal of Cancer|January 9, 2004
Nadir prostate-specific antigen best predicts the progression to androgen-independent prostate cancerJuan Morote, Enrique Trilla, Salvador Esquena, et al.Molecular Diagnosis & Therapy|April 26, 2022
Proclarix, A New Biomarker for the Diagnosis of Clinically Significant Prostate Cancer: A Systematic ReviewMíriam Campistol, Juan Morote, Lucas Regis, et al.Pageof 17